the largest stock of the rinderpest virus was destroyed at the Pirbright Institute.
On Jun. 14, 2019, the Pirbright Institute announced that it had destroyed the last samples of rinderpest virus…
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
Groundbreaking DNA study launched to discover new connections between genetics & diseases
On Jun. 12, 2019, Intermountain Healthcare and deCODE genetics announced a major global collaboration and study focused on…
Genentech drug Polivy (polatuzumab vedotin-piiq) granted accelerated approval by FDA
On Jun. 10, 2019, Genentech drug Polivy (polatuzumab vedotin-piiq) announced the U.S. Food and Drug Administration (FDA) had…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Vaccine
Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
The Richard N Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
Chembio Diagnostics announced approval of Dengue point-of-care test by Brazilis Health Regulatory Agency
On May 7, 2019, Chembio Diagnostics announced the approval of its DPP Dengue System by Agência Nacional de…
Masonic Cancer Center researchers discovered importance of protein p300 acetyltransferase in liver cancer development
On May 3, 2019, Masonic Cancer Center researcher Dr. Ningling Kang and colleauges at The Hormel Institute announced…
U.S. FDA Approved Arctic® Fuji Apple
On May 2, 2019, the U.S. Food and Drug Authority (FDA) announced it had completed its voluntary review…
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 29, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
Biotechnology | Cloning | Disease | Genomics | Medicine | Therapeutics
Moratorium on heritable genome editing published in Nature
On Mar. 13, 2019, Eric Lander, Franooise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg and specialists from seven…
Scientists described the first-ever successful in situ collection of a bacteria that eats and breathes electricity
On Mar. 5, 2019, scientists at Washington State University described the first-ever successful in situ collection of a…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
ICON acquired MolecularMD
On Feb. 21, 2019, ICON announced that it had acquired MolecularMD, a molecular diagnostic specialty laboratory that enables…
Biotechnology | CDC | Vaccine
CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness
On Feb. 15, 2019, the U.S. Centers for Disease Control and Prevention (CDC) published ACIP recommendations for use….
Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
Ontario Institute for Cancer Research leukemia therapy discovery received approximately $1 billion in funding from Celgene
On Jan. 29, 2019, Ontario Institute for Cancer Research’s (OICR) Drug Discovery Program’s first-of-its-kind leukemia therapy discovery received…